Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $40.9 million.

  • Treace Medical Concepts' Total Current Liabilities rose 691.27% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 691.27%. This contributed to the annual value of $34.9 million for FY2024, which is 2244.58% down from last year.
  • Treace Medical Concepts' Total Current Liabilities amounted to $40.9 million in Q3 2025, which was up 691.27% from $41.9 million recorded in Q2 2025.
  • Treace Medical Concepts' Total Current Liabilities' 5-year high stood at $47.0 million during Q1 2024, with a 5-year trough of $8.6 million in Q1 2021.
  • Its 5-year average for Total Current Liabilities is $28.7 million, with a median of $30.2 million in 2022.
  • Per our database at Business Quant, Treace Medical Concepts' Total Current Liabilities surged by 11057.54% in 2022 and then crashed by 2947.78% in 2025.
  • Over the past 5 years, Treace Medical Concepts' Total Current Liabilities (Quarter) stood at $18.2 million in 2021, then surged by 66.09% to $30.2 million in 2022, then skyrocketed by 48.89% to $45.0 million in 2023, then decreased by 22.45% to $34.9 million in 2024, then increased by 17.13% to $40.9 million in 2025.
  • Its last three reported values are $40.9 million in Q3 2025, $41.9 million for Q2 2025, and $33.2 million during Q1 2025.